[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.220.238. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1977

Topical Therapy for Onychomycosis

Arch Dermatol. 1977;113(3):378. doi:10.1001/archderm.1977.01640030124032

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor.—  Chronic onychomycosis generally has required oral antifungal agents for therapy. The introduction of flucytosine for the treatment of systemic and topical fungal diseases has prompted the use of another fluorinated pyrimidine, fluorouracil (5FU), in the treatment of onychomycosis. Fluorouracil, in addition to being effective in the treatment of actinic keratoses, has also been shown to be effective for psoriasis of the nails (110:735, 1974).Briefly, patients were entered into a double-blind study of a solution containing 1% fluorouracil in propylene glycol vs placebo solution (propylene glycol) with proved onychomycosis (as made evident by potassium hydroxide preparation and culture on Sabouraud agar). Three-week intervals were allowed between visits. Photographs were taken of the affected nails in addition to the laboratory tests. At the end of 12 weeks of therapy, a decision was made as to whether the patient had been receiving the "active" medication or the "placebo" medication

First Page Preview View Large
First page PDF preview
First page PDF preview
×